The table below shows SUPERNUS PHARMACEUTICALS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
$23.39M
$18.96M
$16.83M
$15.76M
$17.58M
$17.92M
Gross profit
-
-
-
-
-
-
R&D
$39.44M
$29.37M
$22.11M
$26.93M
$29.04M
$26.18M
SG&A
SUPN annual revenue (10-K history)
SUPERNUS PHARMACEUTICALS, INC. reported annual revenue of $718.95M for fiscal year 2025. That is up 8.6% from $661.82M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $215.00M (FY 2016) to $718.95M. Figures come from the company's audited annual reports as filed with the SEC.